We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Evidence and guidance for healthcare professionals who treat young teens: includes resources and best practice.
Assessing variation in the premature mortality and excess premature mortality for adults with severe mental illness (SMI) during the COVID-19 pandemic.
Policy and guidance for prison and probation professionals in England and Wales.
Outlines the action being taken to improve the experience of people with learning disabilities in hospital and reduce premature deaths.
This study takes place in a maternity Hospital in Central African Republic
A planning tool to examine factors that influence stillbirth and infant death at the population level, rather than in individual clinical care.
The NHS Medical Director, Bruce Keogh, is highlighting the HIV diagnosis campaign being run during National HIV Testing Week
A leaflet for parents which describes the immunisations offered to premature babies.
Rules and guidance for prison and CRC staff on how to settle people into prison during the first days of custody.
An analytical cross-sectional study using routine dried blood spot data from the National Microbiology Reference Laboratory
Permits early use of international standard EN 17339:2020, which comes into force in 2023.
How to do a VAT Return, pay your VAT bill, correct errors in your VAT Return, what to do if you're late with your return or payment.
Following MHRA approval of a clinical trial, early breast cancer patients on endocrine-based therapy can benefit from a study with camizestrant.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).